USHASRI CHALLA

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology WICHITA, KS NPI 1992756563

General Payments — all program years on this page

$3,105.28

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 167
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $727.09 across 38 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $727.0938

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $363.3222
2019 $572.9730
2020 $49.863
2021 $32.251
2022 $542.5831
2023 $817.2142
2024 $727.0938

Records — PY2024 (38)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086749201 Novartis Pharmaceuticals Corporation $22.78 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086749205 Novartis Pharmaceuticals Corporation $21.50 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086749209 Novartis Pharmaceuticals Corporation $25.98 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086749211 Novartis Pharmaceuticals Corporation $23.47 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097556789 Novo Nordisk Inc $22.13 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104551484 AstraZeneca Pharmaceuticals LP $15.91 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105726687 AstraZeneca Pharmaceuticals LP $17.32 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105733893 AstraZeneca Pharmaceuticals LP $14.46 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105828155 AstraZeneca Pharmaceuticals LP $13.91 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105857276 AstraZeneca Pharmaceuticals LP $15.18 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112843300 OPKO Pharmaceuticals, LLC $19.30 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112843302 OPKO Pharmaceuticals, LLC $17.82 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112843304 OPKO Pharmaceuticals, LLC $15.64 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112843306 OPKO Pharmaceuticals, LLC $17.25 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112843308 OPKO Pharmaceuticals, LLC $18.42 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112843310 OPKO Pharmaceuticals, LLC $13.08 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112843312 OPKO Pharmaceuticals, LLC $17.32 07/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1112843314 OPKO Pharmaceuticals, LLC $14.77 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115489132 Amgen Inc. $13.97 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118265699 Boehringer Ingelheim Pharmaceuticals, Inc. $21.42 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118265701 Boehringer Ingelheim Pharmaceuticals, Inc. $23.88 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124038648 Vifor Pharma, Inc. $23.27 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124066088 Vifor Pharma, Inc. $13.22 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139916131 GENZYME CORPORATION $26.23 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141515437 CALLIDITAS THERAPEUTICS US INC. $22.25 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141517513 CALLIDITAS THERAPEUTICS US INC. $25.54 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141522151 CALLIDITAS THERAPEUTICS US INC. $19.64 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141526960 CALLIDITAS THERAPEUTICS US INC. $19.54 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141529709 CALLIDITAS THERAPEUTICS US INC. $18.98 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144616541 Xeris Pharmaceuticals, Inc. $22.36 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144616543 Xeris Pharmaceuticals, Inc. $22.10 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145055111 Mallinckrodt Hospital Products Inc. $19.53 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146674390 Ardelyx, Inc. $21.76 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146674392 Ardelyx, Inc. $18.80 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150677697 Aurinia Pharma U.S., Inc. $16.13 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150677699 Aurinia Pharma U.S., Inc. $16.70 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150677701 Aurinia Pharma U.S., Inc. $19.12 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154208526 Fresenius USA Marketing, Inc. $16.41 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.